CBLLCeriBell, Inc.
$23.15+96% 1Y
$23.15
$10.9252 weeks$25.01
Is the price fair?
What CBLL's price assumes
CeriBell, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 7.32× revenue.
7.32
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 4.94
Price / book · as of 2026-Q1
- EV / sales
- 7.07
EV / sales
Details›
- Price / bookas of 2026-Q1
- 4.94
- EV / EBIToperating margin −69%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 7.07
- Market capitalisation
- $878M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
The closest names by size in the same industry